Cargando…

Fibroblast heterogeneity and tertiary lymphoid tissues in the kidney

Fibroblasts reside in various organs and support tissue structure and homeostasis under physiological conditions. Phenotypic alterations of fibroblasts underlie the development of diverse pathological conditions, including organ fibrosis. Recent advances in single‐cell biology have revealed that fib...

Descripción completa

Detalles Bibliográficos
Autores principales: Arai, Hiroyuki, Sato, Yuki, Yanagita, Motoko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8360208/
https://www.ncbi.nlm.nih.gov/pubmed/33951198
http://dx.doi.org/10.1111/imr.12969
_version_ 1783737701513560064
author Arai, Hiroyuki
Sato, Yuki
Yanagita, Motoko
author_facet Arai, Hiroyuki
Sato, Yuki
Yanagita, Motoko
author_sort Arai, Hiroyuki
collection PubMed
description Fibroblasts reside in various organs and support tissue structure and homeostasis under physiological conditions. Phenotypic alterations of fibroblasts underlie the development of diverse pathological conditions, including organ fibrosis. Recent advances in single‐cell biology have revealed that fibroblasts comprise heterogeneous subpopulations with distinct phenotypes, which exert both beneficial and detrimental effects on the host organs in a context‐dependent manner. In the kidney, phenotypic alterations of resident fibroblasts provoke common pathological conditions of chronic kidney disease (CKD), such as renal anemia and peritubular capillary loss. Additionally, in aged injured kidneys, fibroblasts provide functional and structural supports for tertiary lymphoid tissues (TLTs), which serve as the ectopic site of acquired immune reactions in various clinical contexts. TLTs are closely associated with aging and CKD progression, and the developmental stages of TLTs reflect the severity of renal injury. In this review, we describe the current understanding of fibroblast heterogeneity both under physiological and pathological conditions, with special emphasis on fibroblast contribution to TLT formation in the kidney. Dissecting the heterogeneous characteristics of fibroblasts will provide a promising therapeutic option for fibroblast‐related pathological conditions, including TLT formation.
format Online
Article
Text
id pubmed-8360208
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-83602082021-08-17 Fibroblast heterogeneity and tertiary lymphoid tissues in the kidney Arai, Hiroyuki Sato, Yuki Yanagita, Motoko Immunol Rev Invited Reviews Fibroblasts reside in various organs and support tissue structure and homeostasis under physiological conditions. Phenotypic alterations of fibroblasts underlie the development of diverse pathological conditions, including organ fibrosis. Recent advances in single‐cell biology have revealed that fibroblasts comprise heterogeneous subpopulations with distinct phenotypes, which exert both beneficial and detrimental effects on the host organs in a context‐dependent manner. In the kidney, phenotypic alterations of resident fibroblasts provoke common pathological conditions of chronic kidney disease (CKD), such as renal anemia and peritubular capillary loss. Additionally, in aged injured kidneys, fibroblasts provide functional and structural supports for tertiary lymphoid tissues (TLTs), which serve as the ectopic site of acquired immune reactions in various clinical contexts. TLTs are closely associated with aging and CKD progression, and the developmental stages of TLTs reflect the severity of renal injury. In this review, we describe the current understanding of fibroblast heterogeneity both under physiological and pathological conditions, with special emphasis on fibroblast contribution to TLT formation in the kidney. Dissecting the heterogeneous characteristics of fibroblasts will provide a promising therapeutic option for fibroblast‐related pathological conditions, including TLT formation. John Wiley and Sons Inc. 2021-05-05 2021-07 /pmc/articles/PMC8360208/ /pubmed/33951198 http://dx.doi.org/10.1111/imr.12969 Text en © 2021 The Authors. Immunological Reviews published by John Wiley & Sons Ltd. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Invited Reviews
Arai, Hiroyuki
Sato, Yuki
Yanagita, Motoko
Fibroblast heterogeneity and tertiary lymphoid tissues in the kidney
title Fibroblast heterogeneity and tertiary lymphoid tissues in the kidney
title_full Fibroblast heterogeneity and tertiary lymphoid tissues in the kidney
title_fullStr Fibroblast heterogeneity and tertiary lymphoid tissues in the kidney
title_full_unstemmed Fibroblast heterogeneity and tertiary lymphoid tissues in the kidney
title_short Fibroblast heterogeneity and tertiary lymphoid tissues in the kidney
title_sort fibroblast heterogeneity and tertiary lymphoid tissues in the kidney
topic Invited Reviews
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8360208/
https://www.ncbi.nlm.nih.gov/pubmed/33951198
http://dx.doi.org/10.1111/imr.12969
work_keys_str_mv AT araihiroyuki fibroblastheterogeneityandtertiarylymphoidtissuesinthekidney
AT satoyuki fibroblastheterogeneityandtertiarylymphoidtissuesinthekidney
AT yanagitamotoko fibroblastheterogeneityandtertiarylymphoidtissuesinthekidney